1. Home
  2. NKSH vs PROF Comparison

NKSH vs PROF Comparison

Compare NKSH & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Bankshares Inc.

NKSH

National Bankshares Inc.

HOLD

Current Price

$42.63

Market Cap

265.7M

Sector

Finance

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.63

Market Cap

263.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKSH
PROF
Founded
1891
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.7M
263.8M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
NKSH
PROF
Price
$42.63
$6.63
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
34.0K
117.9K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
4.22%
N/A
EPS Growth
100.81
25.89
EPS
1.57
N/A
Revenue
$8,176,000.00
$16,098,000.00
Revenue This Year
N/A
$92.40
Revenue Next Year
N/A
$64.10
P/E Ratio
$27.15
N/A
Revenue Growth
9.39
50.73
52 Week Low
$27.00
$3.92
52 Week High
$43.27
$8.95

Technical Indicators

Market Signals
Indicator
NKSH
PROF
Relative Strength Index (RSI) 68.75 39.86
Support Level $34.46 $6.68
Resistance Level N/A $7.03
Average True Range (ATR) 1.56 0.49
MACD 0.18 -0.13
Stochastic Oscillator 87.12 8.21

Price Performance

Historical Comparison
NKSH
PROF

About NKSH National Bankshares Inc.

National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural loans, commercial real estate, construction loans for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary. The company earns its revenue from interest and fees on loans, non-interest income, and investments.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: